FDA
-
-
-
-
-
-
-
Daré Bioscience publishes Phase 1 sildenafil cream data in men
-
-
-
-
-
-
-
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
-
-
-
-
-
-
-
Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment
-
-
-
-
-
-
-
Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Daré Bioscience Participates in Virtual Investor “What This Means” Segment
-
-
-
-
-
-
-
Dare Bioscience regains rights to contraceptive drug from Bayer
-
-
-
-
-
-
-
Daré Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Bro
-
335,205 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


